Hopes rise for Shire sale as Takeda CEO discusses case for deal

LONDON (Reuters) - Expectations that Takeda Pharmaceutical will bid for London-listed rare disease specialist Shire before an April 25 deadline rose on Thursday after comments from the head of the Japanese drugmaker on the merits of a deal.

from Reuters: Top News http://uk.reuters.com/article/uk-shire-m-a-takeda-pharma/hopes-rise-for-shire-sale-as-takeda-ceo-discusses-case-for-deal-idUKKCN1HC1WI?feedType=RSS&feedName=topNews